Colgate-Palmolive Co.
John Hazlin (Chief Growth Officer) sells CL shares
AI-generated summary
Chief Growth Officer John Hazlin exercised stock options for 23,376 shares at $77.04 worth $1,800,887.04. He also sold 23,376 shares at an average price of $99.15 worth $2,317,681.31. After these transactions, he directly held 27,021 shares.
Key facts
- Insider
- John Hazlin · Chief Growth Officer
| Date | Transaction | Shares | Price | Value | Held after | Ownership |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | M · exercise or conversion of a derivativeFootnotes F1 | +23,376 | $77.04 | $1,800,887.04 | 50,397 | Direct |
| Nov 4, 2026 | S · open-market saleFootnotes F2, F3 | −23,376 | $99.15 | $2,317,681.31 | 27,021 | Direct |
| Nov 4, 2026 | M · exercise or conversion of a derivativeStock Option (Right to Buy)Footnotes F1, F4 | −23,376 | $0.00 | $0.00 | 0 | Direct |
Footnotes
- F1 Exercise of stock options awarded under the issuer's incentive compensation plan.
- F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
- F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $98.93 to $99.29, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4 Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2021 grant date.
More CL filings
- 4
Filed Nov 6, 2026
- 4
Filed Nov 6, 2026
- 144
Filed Nov 5, 2026
- 144
Filed Nov 5, 2026
- 144
Filed Nov 4, 2026
- 144
Filed Nov 4, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.